EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Surgical treatment of brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia: a single-center experience

Joseph Frantzias, Jacob H Bagley, Gary K Steinberg

Journal of Neurosurgery · 2024

DOI: 10.3171/2024.3.jns232645 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurosurgery, 2024. Verfasst von Joseph Frantzias und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Telangiectasia, Hereditary Hemorrhagic, Intracranial Arteriovenous Malformations. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Hereditary hemorrhagic telangiectasia (HHT) is an autosomal-dominant disorder characterized by multiple vascular malformations. Brain arteriovenous malformations (bAVMs) are a significant manifestation of HHT. The surgical management of these lesions in patients with HHT remains debated, with limited literature on postoperative outcomes. The goal of this study was to evaluate the safety and efficacy of surgical treatment for bAVMs in patients with HHT and propose a treatment rationale based on a single-center experience. METHODS This retrospective review included 20 patients diagnosed with HHT who underwent resection of 23 bAVMs at the Stanford University Medical Center between January 2007 and September 2023. Data were also collected on bAVMs treated conservatively, with embolization, or with radiosurgery at the authors’ institution, for comparison. RESULTS There were 16 Spetzler-Martin (SM) grade I, 6 SM grade II, and 1 SM grade IV bAVM. Six of the bAVMs presented with neurological symptoms (3 with hemorrhage and 3 with focal neurological deficits), while the rest were detected on routine screening. Complete excision was angiographically confirmed in all patients, with a mean overall hospital stay of 2.1 days and a mean follow-up of 36 months. Postoperative complications were limited to transient mild weakness in 2 patients, 1 of whom also had transient speech deficits, and visual field deficits in 3 patients, 2 of whom improved on long-term follow-up. CONCLUSIONS In this most extensive surgical series published to date, resection of bAVMs in patients with HHT showed favorable outcomes with a low complication rate, suggesting that the benefits of surgery outweigh the risks, especially considering the potential cumulative lifetime risk of hemorrhage. MR arterial spin labeling was found to be the most sensitive noninvasive measure of detecting bAVMs in patients with HHT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Telangiectasia, Hereditary HemorrhagicIntracranial Arteriovenous MalformationsHumansMaleFemaleMiddle AgedRetrospective StudiesAdultTreatment OutcomeAgedYoung AdultEmbolization, TherapeuticPostoperative ComplicationsRadiosurgeryNeurosurgical ProceduresAdolescent

Stichwörter der Autor:innen

arterial spin labelingbrain arteriovenous malformationhereditary hemorrhagic telangiectasiasingle-center studysurgical treatmentvascular disorders

Zitieren

APA

Frantzias, J., Bagley, J. H., & Steinberg, G. K. (2024). Surgical treatment of brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia: a single-center experience. Journal of Neurosurgery. https://doi.org/10.3171/2024.3.jns232645

Vancouver

Frantzias J, Bagley JH, Steinberg GK. Surgical treatment of brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia: a single-center experience. Journal of Neurosurgery. 2024. doi:10.3171/2024.3.jns232645

BibTeX
@article{Frantzias2024,
  author = {Frantzias, Joseph and Bagley, Jacob H and Steinberg, Gary K},
  title = {Surgical treatment of brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia: a single-center experience},
  journal = {Journal of Neurosurgery},
  year = {2024},
  doi = {10.3171/2024.3.jns232645}
}
Kostenlos starten →